Two scales for measuring symptom reduction of schizophrenia patients are commonly used in clinical trials, making comparisons of data across studies a challenge at best.
Source:Geddes J et al; BMJ2000; 321:1371-76.
Download citation file:
Please confirm that your email address is correct, so you can successfully receive this alert.
Read this week's Update
Sign Up for Psychiatric News Update newsletter